High-Fat Mouse Model to Explore the Relationship between Abnormal Lipid Metabolism and Enolase in Pancreatic Cancer

<div>Clinical data analysis of pancreatic cancer patients and control group. (a–c) Expression and correlation analysis of triglyceride and NSE in pancreatic cancer patients. (d) ROC curve was used to evaluate the predictive value of triglyceride in pancreatic cancer. (e) Immunohistochemistry was used to detect the expression of ENO1, ENO2, and ENO3 in clinical tissues. (f) Analysis of neuron-specific enolase (NSE) and tumor-related indicators.</div>

Mediators of Inflammation

fig1

Figure 1

Figure 1: High-Fat Mouse Model to Explore the Relationship between Abnormal Lipid Metabolism and Enolase in Pancreatic Cancer 